Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-031830
Filing Date
2022-11-14
Accepted
2022-11-14 13:43:35
Documents
41
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 386687
2 ex31.htm EX-31 11631
3 ex32.htm EX-32 5743
  Complete submission text file 0001493152-22-031830.txt   1927037

Data Files

Seq Description Document Type Size
4 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT qtxb-20220930.xsd EX-101.SCH 15932
5 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT qtxb-20220930_cal.xml EX-101.CAL 28138
6 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT qtxb-20220930_def.xml EX-101.DEF 54824
7 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT qtxb-20220930_lab.xml EX-101.LAB 140311
8 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT qtxb-20220930_pre.xml EX-101.PRE 114934
35 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 182684
Mailing Address P.O. BOX 4960 TUALATIN OR 97062
Business Address P.O. BOX 4960 TUALATIN OR 97062 267-880-1595
QUANTRX BIOMEDICAL CORP (Filer) CIK: 0000820608 (see all company filings)

EIN.: 330202574 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-17119 | Film No.: 221383460
SIC: 3841 Surgical & Medical Instruments & Apparatus